Baseline characteristics | Mean ± SD, median [IQR], n (%) | p-value | |
---|---|---|---|
Intervention (n = 14) | Control (n = 12) | ||
Age, year | 43.14 ± 9.80 | 43.00 ± 13.20 | 0.98 |
Waist circumference, cm | 87.36 ± 6.26 | 94.33 ± 8.93 | 0.03* |
BMI, kg/m2 | 24.84 ± 2.60 | 27.21 ± 3.42 | 0.06 |
HTN, n (%) | 1 (7.14%) | 1 (8.33%) | 1.00 |
DLP, n (%) | 1 (7.14%) | 2 (16.67%) | 0.58 |
SBP, mmHg | 120.50 [115.75, 125.25] | 127.5 [119.25, 142.00] | 0.09 |
DBP, mmHg | 78.07 ± 12.58 | 82.67 ± 12.51 | 0.36 |
TC, mg/dL | 237.36 ± 33.28 | 255.17 ± 32.47 | 0.18 |
TG, mg/dL | 121.00 [89.25, 168.25] | 178.00 [102.75, 244.75] | 0.21 |
HDL-c, mg/dL | 52.93 ± 11.65 | 52.00 ± 12.42 | 0.85 |
LDL-c, mg/dL | 173.50 ± 28.31 | 181.00 ± 33.37 | 0.54 |
AST, U/L | 21.50 [19.00, 29.50] | 22.50 [18.00, 30.25] | 0.71 |
ALT, U/L | 29.00 [19.00, 33.25] | 40.5 [20.00, 51.75] | 0.21 |
FPG, mg/dL | 92.71 ± 8.21 | 89.92 ± 5.30 | 0.32 |
fasting insulin, mIU/L † | 6.75 ± 2.43 | 8.27 ± 4.62 | 0.30 |
fasting GLP-1, pg/mL † | 43.50 ± 19.51 | 50.19 ± 21.90 | 0.48 |
HOMA-B † | 74.47 [58.85, 110.15] | 77.57 [60.23, 146.16] | 0.70 |
HOMA-IR † | 1.47 [1.00, 2.11] | 1.68 [1.00, 1.95] | 0.36 |
Insulin resistance, n (%) † | 7 (50.00%) | 7 (63.63%) | 0.70 |